Hexa Research Inc.
This presentation is the property of its rightful owner.
Sponsored Links
1 / 5

Peptide Therapeutics Market Analysis, Market Size, Share, Regional Outlook,... PowerPoint PPT Presentation


The other growth drivers of this market are introduction of technological advancements such as hybrid method of synthesis of peptides, lifestyle induced diseases such as obesity & diabetes, sophisticated healthcare infrastructure, increasing population and awareness.

Download Presentation

Peptide Therapeutics Market Analysis, Market Size, Share, Re...

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Peptide therapeutics market analysis market size share regional outlook industry trends competitive strategies and

Hexa Research Inc.

Industry Research,Custom Research & Consulting

Peptide Therapeutics Market Analysis, Market Size, Share,

Regional Outlook, Industry Trends, Competitive Strategies

And Segment Forecast From 2012 To 2020

Industry Insights

Peptide therapeutics market is expected to grow over the forecast period owing to the increasing

prevalence of cancer and other various metabolic diseases. The other growth drivers of this market are

introduction of technological advancements such as hybrid method of synthesis of peptides, lifestyle

induced diseases such as obesity & diabetes, sophisticated healthcare infrastructure, increasing

population and awareness.

Peptides are referred as amide bonds which are linked with small chains of amino acid monomers.

Peptides differ from protein on the basis of size. The presence of amino acids in peptides is less than 55

molecules. Peptides crunch themselves to some imitate such as receptor ligands and specific cell surface

receptors. As peptides act on cell membrane, so it helps peptides in treating various diseases.

Browse Detail Report With TOC @ http://www.hexaresearch.com/research-report/peptide-

therapeutics-industry/


Peptide therapeutics market analysis market size share regional outlook industry trends competitive strategies and

Hexa Research Inc.

Industry Research,Custom Research & Consulting

As the market has a huge potential, thus various biotechnology and pharmaceutical industries are

developing new peptides that can be used for various purposes. So these companies are actively

investing in high R&D activities. Globally, cancer has been a foremost cause of death. As per the recent

report published by WHO, it says that as of 2012, total number of cancer patient increased to 12.9

million and it is expected to be 16.2 million over the forecast period.

Peptide therapeutics market is expected to boost owing to rise in metabolic diseases such as obesity &

diabetes and further with growth in number of cancer patients. Various routes of administration and

technologies in peptides have developed due to continuous R&D. In 2103, parenteral route of peptides

has captured highest revenue share. Parenteral route is one of the conventional routes of

administration. In 2013, long phase peptide synthesis has dominated the technology phase. The market

serves the huge opportunity over the upcoming five years.

Technology Insight

Peptide therapeutics market is segmented on the basis of technology into HPPS, LPPS and SPPS. Among

these SPPS technology held the largest market share in 2013 due to user friendliness and cost effective.

In recent years HPSS technology has generated huge momentum and it is expected to be fastest growing

technology over the forecast period.

Application Insights

Peptide therapeutics market is segmented on the basis of application into metabolic, cancer, CNS and

CVS. In 2013, Peptide therapeutics had occupied most of the market share as it is used for treatment of

cancer. Growing incidences of cancer and awareness is expected to drive the market over the forecast

period.

Request A Sample copy of This Report @ http://www.hexaresearch.com/sample/169

Segment (Route of Administration) Insight

Peptide therapeutics market is segmented on the basis route of administration into oral, parenteral,

mucosal and pulmonary. Among these parenteral routes held the largest market share in 2013, as it is

used for a long time. Over the upcoming five years higher comfort level of patients is expected to drive

the parenteral route.


Peptide therapeutics market analysis market size share regional outlook industry trends competitive strategies and

Hexa Research Inc.

Industry Research,Custom Research & Consulting

Product Insight

Peptide therapeutics market is segmented on the basis product types into generic and innovative.

Among these, innovative peptides held the largest market share in 2013, as it is cost effective as

compared to generic peptides. With the help of technological advancement it is expected to grow over

the forecast period.

Regional Insights

Geographically, the Peptide therapeutics market is studied by segmenting the market into North

America, Europe, Asia Pacific and RoW. North America is dominating the whole market due to high per

capita healthcare expenditure, sophisticated healthcare infrastructure, rising disposable income, various

government or NGO’s initiatives and increasing geriatric population. Asia Pacific is expected to witness

lucrative growth rate over the forecast period due to increasing population, government initiatives and

growing economies.

Competitive Insights

The major market players in the Peptide therapeutics market are Bristol-Myers Squibb (BMS), Amylin

Pharmaceuticals LLC, Bachem Holding AG, Roche, Amgen Inc., Peptisyntha, Ipsen, Eli Lilly and Company,

AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Merck & Co., Lonza Inc., Novartis AG,

GlaxoSmithKline (GSK), PolyPeptide Group, Novo-Nordisk A/S, Pfizer Inc., Sanofi, and Teva

Pharmaceuticals.

Table of Contents

Chapter 1 Executive Summary

1.1 Peptide Therapeutics – Industry Summary & Critical Success Factors (CSFs)

Chapter 2 Peptide Therapeutics Industry Outlook

2.1 Market Segmentation

2.2 Market Size and Growth Prospects

2.3 Peptide Therapeutics Value Chain Analysis

2.4 Peptide Therapeutics Market Dynamics

2.5 Key Opportunities Prioritized

2.6 Industry Analysis - Porter's


Peptide therapeutics market analysis market size share regional outlook industry trends competitive strategies and

Hexa Research Inc.

Industry Research,Custom Research & Consulting

2.7 Peptide Therapeutics - Company Market Share Analysis

2.8 Peptide Therapeutics - PESTEL Analysis

Chapter 3 Peptide TherapeuticsTechnologyOutlook

3.1 Solid Phase Peptide Synthesis (SPPS)

3.2 Liquid Phase Peptide Synthesis (LPPS)

3.3 Hybrid Phase Peptide Synthesis (HPSS)

Browse All Healthcare IT Industry Research Related Reports @

http://www.hexaresearch.com/research-category/healthcare-it-industry/

Chapter 4 Peptide Therapeutics Application Outlook

4.1 Cancer

4.2 Metabolic

4.3 Cardiovascular

4.4 Dermatology

4.5 Anti-infection

4.6 Gastro Intestinal

4.7Renal

4.8 Respiratory

Chapter 5 Peptide Therapeutics Route Outlook

5.1 Parenteral Route

5.2 Oral Route

5.3 Pulmonary Route

5.4 Mucosal Route

5.5 Other Routes (Intradermal & Nasal)

Chapter 6 Peptide Therapeutics Product Outlook

6.1 Innovative

6.2 Generic

Chapter 7 Peptide Therapeutics Regional Outlook

7.1 North America

7.2 Europe

7.3 Asia Pacific


Peptide therapeutics market analysis market size share regional outlook industry trends competitive strategies and

Hexa Research Inc.

Industry Research,Custom Research & Consulting

7.4 RoW

Chapter 8 Competitive Landscape

8.1 Amgen Inc.

8.2 Amylin Pharmaceuticals LLC- Bristol- Myers Squibb (BMS)

8.3 AstraZeneca PLC

8.4 Bachem Holding AG

8.5 Eli Lilly and Company

8.6 GlaxoSmithKline (GSK)

8.7 Ipsen

8.8 Lonza Inc.

Chapter 9 Methodology & Scope

9.1 Research Methodology

9.2 Research Scope & Assumptions

9.3 List of Data Sources

Browse Full Report @ http://www.hexaresearch.com/research-report/peptide-therapeutics-industry/

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom

research and consulting services to a host of key industries across the globe. We offer comprehensive

business intelligence in the form of industry reports which help our clients obtain clarity about their

business environment and enable them to undertake strategic growth initiatives.

Contact Information:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: [email protected]

Website - http://www.hexaresearch.com/

Visit our Blogs: http://2015hexaresearchpapers.blogspot.com/


  • Login